BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Sativex regulatory update

GW submitted regulatory applications in about 10 European countries for Sativex to treat spasticity due to multiple sclerosis under the mutual recognition procedure. The U.K. is acting as the reference member state. The company expects the procedure to be completed by mid-2012....

Read the full 188 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >